title: Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity.
abstract: tau, a microtubule-associated protein, directly binds with microtubules to dynamically regulate the organization of cellular cytoskeletons, and is especially abundant in neurons of the central nervous system. Under disease conditions such as Pick's disease, progressive supranuclear palsy, frontotemporal dementia, parkinsonism linked to chromosome 17 and Alzheimer's disease, tau proteins can self-assemble to paired helical filaments progressing to neurofibrillary tangles. In these diseases, collectively referred to as "tauopathies", alterations of diverse tau modifications including phosphorylation, metal ion binding, glycosylation, as well as structural changes of tau proteins have all been observed, indicating the complexity and variability of factors in the regulation of tau toxicity. Here, we review our current knowledge and hypotheses from relevant studies on tau toxicity, emphasizing the roles of phosphorylations, metal ions, folding and clearance control underlining tau etiology and their regulations. A summary of clinical efforts and associated findings of drug candidates under development is also presented. It is hoped that a more comprehensive understanding of tau regulation will provide us with a better blueprint of tau networking in neuronal cells and offer hints for the design of more efficient strategies to tackle tau-related diseases in the future.
authors.affiliation: State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua University, Beijing, 100084, China.
authors.forename: Yunpeng
authors.initials: Y
authors.lastname: Huang
authors.affiliation: Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
authors.forename: Zhihao
authors.initials: Z
authors.lastname: Wu
authors.affiliation: State Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua University, Beijing, 100084, China. zhoubing@mail.tsinghua.edu.cn.|Beijing Institute for Brain Disorders, Beijing, China. zhoubing@mail.tsinghua.edu.cn.
authors.forename: Bing
authors.initials: B
authors.lastname: Zhou
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology; D000818:Animals; D001921:Brain / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007167:Immunotherapy; D008670:Metals / Q000378:metabolism; D016874:Neurofibrillary Tangles / Q000378:metabolism / Q000473:pathology; D009474:Neurons / Q000378:metabolism / Q000473:pathology*; D010766:Phosphorylation; D066263:Protein Aggregation, Pathological / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D017510:Protein Folding; D059748:Proteolysis; D024801:Tauopathies / Q000378:metabolism* / Q000473:pathology* / Q000628:therapy; D016875:tau Proteins / Q000032:analysis / Q000378:metabolism*
chemical_list: D008670:Metals; D016875:tau Proteins
keywords: Chaperon; Degradation; Hyperphosphorylation; Therapeutic strategy; Zinc